兰索拉唑联合莫沙必利治疗反流性食管炎的临床体会

Blue Zola zuo union not Sha Bili treats the regurgitation esophagitis's clinical experience

目的:探讨兰索拉唑联合莫沙必利治疗反流性食管炎(RE)的临床体会。方法:对使用兰索拉唑联合莫沙必利和使用法莫替丁联合莫沙必利治疗RE的各50例资料进行分析和讨论。结果:6周后治疗组总有效率为94%,复发率为6%;观察组总有效率和复发率分别为78%和20%。结论:兰索拉唑联合莫沙必利治疗RE,疗效好,复发率低,值得推广。

Goal： Discusses blue Zola zuo union not Sha Bili treats the regurgitation esophagitis （RE） clinical experience. Method： For uses blue Zola zuo union not Sha Bili and the operation not unites not Sha Bili for Ding to treat RE each 50 example material to carry on the analysis and the discussion. Finally： 6 weeks later treats the group total effectiveness is 94%, the recurrence rate is 6% ; Observation group total effectiveness and the recurrence rate respectively are 78% and 20%. Conclusion： Blue Zola zuo union not Sha Bili treats RE, the curative effect is good, the re- currence rate is low, is worth promoting.